Liquid Biopsy Market Market USD 3,362.6 million by 2026 | CAGR: 21.9%
Liquid Biopsy Market Size Worth USD 3,362.6 million by 2026
“According to Polaris Market Research report, Liquid Biopsy Market is witnessing major innovations & transformations and is anticipated to reach USD 3,362.6 million by 2026, registering a CAGR of 21.9% during the forecast period 2019 to 2026. The global Liquid Biopsy Market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2026 The market analysis covered in the report includes data in terms of value $3,362.6 Million.The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market.
Liquid Biopsy Market Report Scope: The global Liquid Biopsy Market is segmented based on application and geography. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market.
-2-
Liquid Biopsy Market Size Worth USD 3,362.6 million by 2026
Application Outlook Sample Type Outlook
Biomarker Outlook
By Region Type By Application Type
• • • • • •
• Spinal • Hip • Knee • Dental Craniomaxillofa • cial S.E.T (Sports Medicine, Extremities, Trauma)
Blood • Urine • Saliva • Other body fluid
Exosomes CTC ctDNA
•
•
•
Molecular Health Monitoring Therapy Selection for Other Meta Cancer Therapy Selection for MBS
• • • • •
North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
•
COVID-19 Impact Analysis for Liquid Biopsy Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its longterm effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Liquid Biopsy Market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities : Browse Detailed Research Report On Liquid Biopsy Market Analysis: https://www.polarismarketresearch.com/industry-analysis/liquid-biopsy-market
Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service.
-3-
Liquid Biopsy Market Size Worth USD 3,362.6 million by 2026
Competitive Landscape The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Liquid Biopsy Market include Roche Diagnostics, Illumina Inc., Myriad Genetics, Inc., RainDance Technologies, Inc. among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/liquid-biopsymarket/request-for-sample
Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4. Key take-away 1.5. Stakeholders 2. Executive Summary 2.1. Market definition 2.2. Market segmentation 3. Liquid Biopsy Market Insights 3.1. Liquid Biopsy– Industry snapshot 3.2. Leading Companies 3.3. Key Companies to Watch 3.4. Liquid Biopsy- Ecosystem analysis 3.5. Disease overview 3.6. Commercial Landscape 3.7. Liquid Biopsy market Dynamics 3.7.1.Liquid Biopsy– Market Forces 3.7.2.Liquid Biopsy Market Driver Analysis 3.7.3.Liquid Biopsy Market Restraint/Challenges analysis 3.7.4.Liquid Biopsy market Opportunity Analysis 3.8. Industry analysis - Porter's five forces 3.8.1.Bargaining power of supplier 3.8.2.Bargaining power of buyer 3.8.3.Threat of substitute 3.8.4.Threat of new entrant 3.9. Degree of competition 3.10. Liquid Biopsy market PEST Analysis, 2017 3.11. Liquid Biopsy Market Value Chain Analysis 3.12. Liquid Biopsy Industry Trends 3.13. Competitive Ranking Analysis -4-
Liquid Biopsy Market Size Worth USD 3,362.6 million by 2026
4. Liquid Biopsy Market Size and Forecast, 2017-2025 by Technology Types 4.1. Key Findings 4.2. Single Gene Analysis (PCR Microarrays) 4.2.1.Global market estimates and forecasts, 2017 – 2025 4.3. Multi-gene-parallel analysis (NGS) 4.3.1.Global market estimates and forecasts, 2017 – 2025 5. Liquid Biopsy Market Size and Forecast, 2017-2025 by Sample type 5.1. Key Findings 5.2. Blood 5.2.1.Global market estimates and forecasts, 2017 – 2025 5.3. Urine 5.3.1.Global market estimates and forecasts, 2017 – 2025 5.4. Saliva 5.4.1.Global market estimates and forecasts, 2017 – 2025 5.5. Other Body Fluids 5.5.1.Global market estimates and forecasts, 2017 – 2025 6. Liquid Biopsy Market Size and Forecast, 2017-2025 by Biomarker type 6.1. Key Findings 6.2. Exosomes 6.2.1.Global market estimates and forecasts, 2017 – 2025 6.3. CTC 6.3.1.Global market estimates and forecasts, 2017 – 2025 6.4. CTCDNAs 6.4.1.Global market estimates and forecasts, 2017 – 2025 7. Liquid Biopsy Market Size and Forecast, 2017-2025 by Application type 7.1. Key Findings 7.2. Molecular Health Monitoring 7.2.1.Global market estimates and forecasts, 2017 – 2025 7.3. Therapy Selection for Other Meta Cancer 7.3.1.Global market estimates and forecasts, 2017 – 2025 7.4. Therapy Selection for MBS 7.4.1.Global market estimates and forecasts, 2017 – 2025 8. Liquid Biopsy Market Size and Forecast, 2017-2025 by Region 8.1. Key Findings 8.2. North America 8.2.1.Liquid Biopsy market by Technology type, 2017-2025 8.2.2.Liquid Biopsy market by Sample, 2017-2025 8.2.3.Liquid Biopsy market by Biomarker, 2017-2025 8.2.4.Liquid Biopsy market by Application, 2017-2025 8.2.5.U.S. 8.2.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.2.5.2. Liquid Biopsy market by Sample, 2017-2025 8.2.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.2.5.4. Liquid Biopsy market by Application, 2017-2025 8.2.6.Canada 8.2.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.2.6.2. Liquid Biopsy market by Sample, 2017-2025 8.2.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.2.6.4. Liquid Biopsy market by Application, 2017-2025 8.3. Europe 8.3.1.Liquid Biopsy market by Technology type, 2017-2025 -5-
Liquid Biopsy Market Size Worth USD 3,362.6 million by 2026
8.3.2.Liquid Biopsy market by Sample, 2017-2025 8.3.3.Liquid Biopsy market by Biomarker, 2017-2025 8.3.4.Liquid Biopsy market by Application, 2017-2025 8.3.5.UK 8.3.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.5.2. Liquid Biopsy market by Sample, 2017-2025 8.3.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.5.4. Liquid Biopsy market by Application, 2017-2025 8.3.6.Germany 8.3.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.6.2. Liquid Biopsy market by Sample, 2017-2025 8.3.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.6.4. Liquid Biopsy market by Application, 2017-2025 8.3.7.France 8.3.7.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.7.2. Liquid Biopsy market by Sample, 2017-2025 8.3.7.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.7.4. Liquid Biopsy market by Application, 2017-2025 8.3.8.Italy 8.3.8.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.8.2. Liquid Biopsy market by Sample, 2017-2025 8.3.8.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.8.4. Liquid Biopsy market by Application, 2017-2025 8.4. Asia-Pacific 8.4.1.Liquid Biopsy market by Technology type, 2017-2025 8.4.2.Liquid Biopsy market by Sample, 2017-2025 8.4.3.Liquid Biopsy market by Biomarker, 2017-2025 8.4.4.Liquid Biopsy market by Application, 2017-2025 8.4.5.China 8.4.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.4.5.2. Liquid Biopsy market by Sample, 2017-2025 8.4.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.4.5.4. Liquid Biopsy market by Application, 2017-2025 8.4.6.Japan 8.4.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.4.6.2. Liquid Biopsy market by Sample, 2017-2025 8.4.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.4.6.4. Liquid Biopsy market by Application, 2017-2025 8.4.7.India 8.4.7.1. Liquid Biopsy market by Technology type, 2017-2025 8.4.7.2. Liquid Biopsy market by Sample, 2017-2025 8.4.7.3. Liquid Biopsy market by Biomarker, 2017-2025 8.4.7.4. Liquid Biopsy market by Application, 2017-2025 8.5. Latin America 8.5.1.Liquid Biopsy market by Technology type, 2017-2025 8.5.2.Liquid Biopsy market by Sample, 2017-2025 8.5.3.Liquid Biopsy market by Biomarker, 2017-2025 8.5.4.Liquid Biopsy market by Application, 2017-2025 8.5.5.Brazil 8.5.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.5.5.2. Liquid Biopsy market by Sample, 2017-2025 -6-
Liquid Biopsy Market Size Worth USD 3,362.6 million by 2026
8.5.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.5.5.4. Liquid Biopsy market by Application, 2017-2025 8.5.6.Mexico 8.5.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.5.6.2. Liquid Biopsy market by Sample, 2017-2025 8.5.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.5.6.4. Liquid Biopsy market by Application, 2017-2025 8.5.7.Rest of Latin America 8.5.7.1. Liquid Biopsy market by Technology type, 2017-2025 8.5.7.2. Liquid Biopsy market by Sample, 2017-2025 8.5.7.3. Liquid Biopsy market by Biomarker, 2017-2025 8.5.7.4. Liquid Biopsy market by Application, 2017-2025 8.6. Middle East & Africa 8.6.1.Liquid Biopsy market by Technology type, 2017-2025 8.6.2.Liquid Biopsy market by Sample, 2017-2025 8.6.3.Liquid Biopsy market by Biomarker, 2017-2025 8.6.4.Liquid Biopsy market by Application, 2017-2025 9. Company Profiles 9.1. Roche Diagnostics 9.1.1.Overview 9.1.2.Financials 9.1.3.Product Benchmarking 9.1.4.Recent Developments 9.2. Illumina, Inc. 9.2.1.Overview 9.2.2.Financials 9.2.3.Product Benchmarking 9.2.4.Recent Developments 9.3. Bio-Rad Laboratories Inc. 9.3.1.Overview 9.3.2.Financials 9.3.3.Product Benchmarking 9.3.4.Recent Developments 9.4. Myriad Genetics, Inc. 9.4.1.Overview 9.4.2.Financials 9.4.3.Product Benchmarking 9.4.4.Recent Developments 9.5. Menarini Silicon Biosystems, Genomic Health, Inc. 9.5.1.Overview 9.5.2.Financials 9.5.3.Product Benchmarking 9.5.4.Recent Developments 9.6. QIAGEN N.V. 9.6.1.Overview 9.6.2.Financials 9.6.3.Product Benchmarking 9.6.4.Recent Developments 9.7. Thermo Fisher Scientific Inc. 9.7.1.Overview 9.7.2.Financials -7-
Liquid Biopsy Market Size Worth USD 3,362.6 million by 2026
9.7.3.Product Benchmarking 9.7.4.Recent Developments 9.8. Biocept, Inc. 9.8.1.Overview 9.8.2.Financials 9.8.3.Product Benchmarking 9.8.4.Recent Developments 9.9. Trovagene, Inc. 9.9.1.Overview 9.9.2.Financials 9.9.3.Product Benchmarking 9.9.4.Recent Developments 9.10. RainDance Technologies, Inc. 9.10.1. Overview 9.10.2. Financials 9.10.3. Product Benchmarking 9.10.4. Recent Developments 9.11. Guardant Health, Inc. 9.11.1. Overview 9.11.2. Financials 9.11.3. Product Benchmarking 9.11.4. Recent Developments 9.12. MDx Health SA. 9.12.1. Overview 9.12.2. Financials 9.12.3. Product Benchmarking 9.12.4. Recent Developments Access Press Release on Liquid Biopsy Market: https://www.polarismarketresearch.com/pressreleases/liquid-biopsy-market
About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com -8-